Influence of rivaroxaban compared to vitamin K antagonist treatment upon development of cardiovascular calcification in patients with atrial fibrillation and/or pulmonary embolism-Reference-Cited by-同舟云学术

Influence of rivaroxaban compared to vitamin K antagonist treatment upon development of cardiovascular calcification in patients with atrial fibrillation and/or pulmonary embolism

Published:2022-03-25 Issue:4 Volume:45 Page:352-358
ISSN:0160-9289
Container-title:Clinical Cardiology
language:en
Short-container-title:Clinical Cardiology

Author:

Stöhr Robert¹,Dirrichs Timm,Kneizeh Kinan¹,Reinartz Sebastian²,Frank Dario³,Brachmann Johannes⁴,Schroeder Joerg¹,Schurgers Leon⁵⁶,Göttsch Claudia¹,Keszei Andras⁷,Floege Jürgen⁸,Marx Nikolaus¹,Brandenburg Vincent⁹,Schuh Alexander¹¹⁰^ORCID

Affiliation:

1. Department of Cardiology RWTH University Hospital Aachen Aachen Germany

2. Department of Radiology RWTH University Hospital Aachen Aachen Germany

3. Department of Internal Medicine St. Antonius Hospital Eschweiler Germany

4. Department of Cardiology Regiomed‐Kliniken Coburg Germany

5. Department of Biochemistry Maastricht University Hospital Maastricht The Netherlands

6. Institute of Experimental Medicine and Systems Biology RWTH Aachen University Aachen Germany

7. Center for Translational and Clinical Research RWTH Aachen University Aachen Germany

8. Department of Nephrology RWTH University Hospital Aachen Aachen Germany

9. Department of Cardiology and Nephrology Rhein‐Maas Klinikum Würselen Germany

10. Department of Cardiology St.‐Katharinen‐Hospital Frechen Germany

Funder